KY HB423 | 2020 | Regular Session

Status

Spectrum: Bipartisan Bill
Status: Introduced on February 12 2020 - 25% progression
Action: 2020-02-14 - to Banking & Insurance (H)
Pending: House Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Create a new section of Subtitle 17A of KRS Chapter 304 to define terms; prohibit certain conduct of health plans and pharmacy benefit managers related to the coverage of certified insulin; provide a process by which manufacturers may have an insulin product determined certified insulin; impose requirements on the commissioner relating to the certification of an insulin product; provide short title.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT relating to the cost of insulin.

Sponsors


History

DateChamberAction
2020-02-14Houseto Banking & Insurance (H)
2020-02-12Houseintroduced in House

Subjects


Kentucky State Sources


Bill Comments

feedback